<DOC>
	<DOCNO>NCT01431989</DOCNO>
	<brief_summary>This study prospective , open-label , randomize , crossover , single dose , 02 treatment , 02 sequence 02 period . The volunteer receive , period , reference test formulation , accord randomization list , fast condition , order evaluate reference test formulation bioequivalent .</brief_summary>
	<brief_title>Amoxicillin Bioequivalence Study Brazil - Fast</brief_title>
	<detailed_description>This study prospective , open-label , randomize , crossover , single dose , 02 treatment , 02 sequence 02 period . The objective confirm two formulation Amoxicillin trihydrate , form powder oral suspension , bioequivalent . The test product Amoxicillin trihydrate - Clamoxyl 500mg/5mL ( Glaxo Wellcome Production . ) form powder oral suspension reference product Amoxil Â® 500mg/5mL ( GlaxoSmithKline Mexico SA ) form powder oral suspension . Twenty eight healthy volunteer , gender , evaluate . The volunteer receive , period , reference test formulation , accord randomization list , fast condition . In period blood sample collect follow time : 0.00 ( prior administration medication ) ; 0.25 ; 0.50 ; 0.75 ; 1.00 ; 1.25 ; 1.50 ; 1.75 ; 2.00 ; 2.50 ; 3.00 ; 4.00 ; 5.00 ; 6.00 ; 8.00 ( administration medication ) . The comparative bioavailability two formulation evaluate base statistical comparison relevant pharmacokinetic parameter , obtain data drug concentration blood .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Age 18 50 year Body mass index 18,5 25,0 , vary 15 % upper limit ( 18,5 28,75 ) Good health condition Obtain sign informed consent Results laboratory test outside normal limit , unless consider clinically irrelevant The volunteer underwent surgery hospitalize reason start study review physician admission study , observe period exclusion 4 8 week Positive test hepatitis B , hepatitis C HIV pre study evaluation Known hypersensitivity study drug compound chemically relate Use experimental drug participation clinical study within 6 month prior study initiation Use regular medication within 2 week prior study initiation History alcohol drug abuse intake alcohol within 24 hour prior period confinement Consume inductive drug and/or enzymatic inhibitor ( CYP450 hepatic ) , toxic organism present long halflife 's elimination within 30 day prior study initiation Use MAO serotonin reuptake inhibitor within 2 week prior study initiation Volunteers psychiatric psychological illness unless consider clinically irrelevant investigator History presence hepatic , renal gastrointestinal illness condition interfere drug 's absorption , distribution , excretion metabolism History neurological , endocrine , pulmonary , hematologic , immune , brain , metabolic cardiovascular illness Hypo hypertension etiologic need pharmacologic treatment History clinical case myocardial infarction , angina and/or heart failure The volunteer donate lose 450 mL blood within 3 month prior study initiation The volunteer condition obstruct his/her participation study accord investigator 's judgement Smoking Positive beta HCG exam woman Breastfeeding woman Women make use contraceptive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>